{
    "organizations": [],
    "uuid": "a6bdf30bce49084a76151b0afd3ad47a241bff9b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-immunovaccine-shareholders-approve/brief-immunovaccine-shareholders-approve-share-consolidation-at-99-85-pct-idUSFWN1S80NB",
    "ord_in_thread": 0,
    "title": "BRIEF-Immunovaccine Shareholders Approve Share Consolidation At 99.85 pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 1 (Reuters) - Immunovaccine Inc:\n* IMMUNOVACCINE SHAREHOLDERS APPROVE SHARE CONSOLIDATION AT 99.85 PCT Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-02T05:22:00.000+03:00",
    "crawled": "2018-05-02T16:03:45.003+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "immunovaccine",
        "inc",
        "immunovaccine",
        "shareholder",
        "approve",
        "share",
        "consolidation",
        "pct",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}